Gregory Renza
Stock Analyst at Truist Securities
(4.06)
# 547
Out of 5,091 analysts
239
Total ratings
40.98%
Success rate
16.24%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Assumes: Buy | $812 → $798 | $703.26 | +13.47% | 1 | Nov 24, 2025 | |
| CATX Perspective Therapeutics | Assumes: Buy | $8 → $12 | $2.40 | +400.00% | 7 | Nov 24, 2025 | |
| NRIX Nurix Therapeutics | Assumes: Buy | $23 → $30 | $21.47 | +39.73% | 12 | Nov 24, 2025 | |
| GILD Gilead Sciences | Assumes: Buy | $145 → $140 | $121.19 | +15.52% | 1 | Nov 24, 2025 | |
| AMGN Amgen | Assumes: Hold | $298 → $318 | $321.23 | -1.01% | 18 | Nov 24, 2025 | |
| XNCR Xencor | Initiates: Buy | $29 | $17.63 | +64.49% | 10 | Nov 24, 2025 | |
| VRDN Viridian Therapeutics | Initiates: Buy | $41 | $31.88 | +28.61% | 12 | Nov 24, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $11 | $8.60 | +27.98% | 7 | Nov 24, 2025 | |
| NUVL Nuvalent | Initiates: Buy | $140 | $107.91 | +29.74% | 1 | Nov 24, 2025 | |
| MNKD MannKind | Initiates: Buy | $9 | $5.63 | +59.86% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $59 | $35.34 | +66.95% | 13 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $13.13 | +6.67% | 4 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $62 | $42.86 | +44.66% | 4 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $10 | $7.36 | +35.87% | 4 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $400 | $326.64 | +22.46% | 3 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $31.31 | +62.89% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $27.28 | +17.30% | 7 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $140 | $115.05 | +21.69% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $35 | $220.10 | -84.10% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $26 | $26.75 | -2.80% | 16 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $8 | $3.23 | +147.68% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $5 | $2.09 | +139.23% | 11 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $42.17 | -5.15% | 10 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $182 → $172 | $168.99 | +1.78% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $113 → $38 | $82.23 | -54.40% | 14 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $12 | $11.26 | +6.57% | 6 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $14 | $10.25 | +36.59% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $18 | $24.34 | -26.05% | 11 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $68 → $48 | $1.72 | +2,690.70% | 4 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $110 → $20 | $8.13 | +146.12% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $16 | $0.81 | +1,864.64% | 1 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $2,160 → $180 | $19.44 | +825.93% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $100 → $80 | $1.05 | +7,519.05% | 5 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $105 → $30 | $0.45 | +6,591.95% | 3 | Jun 2, 2020 |
Regeneron Pharmaceuticals
Nov 24, 2025
Assumes: Buy
Price Target: $812 → $798
Current: $703.26
Upside: +13.47%
Perspective Therapeutics
Nov 24, 2025
Assumes: Buy
Price Target: $8 → $12
Current: $2.40
Upside: +400.00%
Nurix Therapeutics
Nov 24, 2025
Assumes: Buy
Price Target: $23 → $30
Current: $21.47
Upside: +39.73%
Gilead Sciences
Nov 24, 2025
Assumes: Buy
Price Target: $145 → $140
Current: $121.19
Upside: +15.52%
Amgen
Nov 24, 2025
Assumes: Hold
Price Target: $298 → $318
Current: $321.23
Upside: -1.01%
Xencor
Nov 24, 2025
Initiates: Buy
Price Target: $29
Current: $17.63
Upside: +64.49%
Viridian Therapeutics
Nov 24, 2025
Initiates: Buy
Price Target: $41
Current: $31.88
Upside: +28.61%
Nuvation Bio
Nov 24, 2025
Initiates: Buy
Price Target: $11
Current: $8.60
Upside: +27.98%
Nuvalent
Nov 24, 2025
Initiates: Buy
Price Target: $140
Current: $107.91
Upside: +29.74%
MannKind
Nov 24, 2025
Initiates: Buy
Price Target: $9
Current: $5.63
Upside: +59.86%
Nov 24, 2025
Initiates: Buy
Price Target: $59
Current: $35.34
Upside: +66.95%
Nov 24, 2025
Initiates: Buy
Price Target: $14
Current: $13.13
Upside: +6.67%
Nov 24, 2025
Initiates: Buy
Price Target: $62
Current: $42.86
Upside: +44.66%
Nov 24, 2025
Initiates: Hold
Price Target: $10
Current: $7.36
Upside: +35.87%
Nov 24, 2025
Initiates: Buy
Price Target: $400
Current: $326.64
Upside: +22.46%
Nov 24, 2025
Initiates: Buy
Price Target: $51
Current: $31.31
Upside: +62.89%
Nov 24, 2025
Initiates: Buy
Price Target: $32
Current: $27.28
Upside: +17.30%
Nov 24, 2025
Initiates: Buy
Price Target: $140
Current: $115.05
Upside: +21.69%
May 23, 2025
Maintains: Outperform
Price Target: $31 → $35
Current: $220.10
Upside: -84.10%
May 19, 2025
Reiterates: Outperform
Price Target: $26
Current: $26.75
Upside: -2.80%
May 15, 2025
Reiterates: Outperform
Price Target: $8
Current: $3.23
Upside: +147.68%
May 14, 2025
Reiterates: Sector Perform
Price Target: $5
Current: $2.09
Upside: +139.23%
May 14, 2025
Reiterates: Outperform
Price Target: $40
Current: $42.17
Upside: -5.15%
May 7, 2025
Maintains: Outperform
Price Target: $182 → $172
Current: $168.99
Upside: +1.78%
Apr 16, 2025
Maintains: Sector Perform
Price Target: $113 → $38
Current: $82.23
Upside: -54.40%
Mar 26, 2025
Reiterates: Outperform
Price Target: $12
Current: $11.26
Upside: +6.57%
Mar 21, 2025
Maintains: Outperform
Price Target: $16 → $14
Current: $10.25
Upside: +36.59%
Jan 14, 2025
Reiterates: Sector Perform
Price Target: $18
Current: $24.34
Upside: -26.05%
Jan 9, 2025
Maintains: Outperform
Price Target: $68 → $48
Current: $1.72
Upside: +2,690.70%
Nov 5, 2024
Downgrades: Sector Perform
Price Target: $110 → $20
Current: $8.13
Upside: +146.12%
Aug 14, 2024
Reiterates: Outperform
Price Target: $16
Current: $0.81
Upside: +1,864.64%
Jun 27, 2023
Downgrades: Sector Perform
Price Target: $2,160 → $180
Current: $19.44
Upside: +825.93%
Mar 16, 2022
Maintains: Sector Perform
Price Target: $100 → $80
Current: $1.05
Upside: +7,519.05%
Jun 2, 2020
Downgrades: Sector Perform
Price Target: $105 → $30
Current: $0.45
Upside: +6,591.95%